natgillin/translations-raw huggingface dataset:
It is not known whether interferon beta-1b is excreted in human milk.
Ni znano, ali se interferon beta-1b izloča v materino mleko.
It is not known whether interferon beta-1b passes into human breast milk.
Ni znano, ali interferon beta-1b prehaja v materino mleko.
It is not known whether ioflupane (123I) is excreted in human milk.
Ni znano, ali se ioflupan (123I) izloča v človeško mleko.
It is not known whether ioflupane (123I) is passed into breast milk.
Ni znano, ali se ioflupan (123I) izloča v človeško mleko.
It is not known whether ipilimumab gets into breast milk.
Ni znano, če se ipilimumab izloča v materino mleko.
It is not known whether Kengrexal is excreted in human milk.
Ni znano, ali se zdravilo Kengrexal izloča v človeško mleko.
It is not known whether linagliptin passes into human milk.
Za linagliptin ni znano, ali se izloča v materino mleko.
It is not known whether Lonsurf changes your ability to drive or use machines.
Ni znano, ali zdravilo Lonsurf spremeni vašo sposobnost upravljanja vozil in strojev.
It is not known whether Lynparza may affect the effectiveness of some oral contraceptives.
Ni znano, ali zdravilo Lynparza poslabša učinkovitost nekaterih kontracepcijskih tablet.
It is not known whether Lynparza passes into breast milk.
Ni znano, ali zdravilo Lynparza prehaja v materino mleko.
It is not known whether MabThera has an effect on you being able to drive or use any tools or machines.
Ni znano, ali zdravilo MabThera vpliva na vašo sposobnost za upravljanje vozil ali strojev.
It is not known whether macitentan is excreted into human breast milk.
Ni znano, ali se macitentan izloča v materino mleko.
It is not known whether maraviroc is secreted into human milk.
Ni znano, ali se maravirok izloča v mleko tudi pri človeku.
It is not known whether memantine has an effect on fertility as there is no data.
Ker ni podatkov, ni znano, ali memantin vpliva na plodnost.
It is not known whether nivolumab gets into breast milk.
Ni znano, če se nivolumab izloča v materino mleko.
It is not known whether Pandemic influenza vaccine H5N1 MedImmune is excreted in human milk.
Ni znano, ali se Cepivo proti pandemski gripi H5N1 MedImmune pri človeku izloča v materino mleko.
It is not known whether pazopanib is excreted in human milk.
Ni znano, če se pazopanib izloča z materinim mlekom.
It is not known whether pegaspargase is excreted into breast milk.
Ni znano, ali se pegaspargaza izloča v materino mleko.
It is not known whether Pixuvri has an effect on the ability to drive a car or use machines.
Ni znano, ali zdravilo Pixuvri vpliva na sposobnost vožnje in upravljanja s stroji.
It is not known whether Pixuvri has an effect on your ability to drive a car or use machines.
Ni znano, ali zdravilo Pixuvri vpliva na sposobnost vožnje in upravljanja s stroji.
It is not known whether radiation therapy could affect the effectiveness of fibrin sealant when used for suture line sealing during neurosurgery.
Ni znano, ali zdravljenje s sevanjem vpliva na učinkovitost fibrinskega lepila, kadar se ta uporablja za lepljenje šivov pri nevrokirurškem posegu.
It is not known whether raltegravir is secreted in human milk.
Ni znano, če se raltegravir pri človeku izloča v materino mleko.
It is not known whether Rebif is excreted in human milk.
Ni znano, ali se zdravilo Rebif izloča v materino mleko.
It is not known whether recent radiation therapy affects the efficacy of Tachosil when used for dura mater sealing.
Ni znano, če zdravljenje z obsevanjem vpliva na učinkovitost zdravila TachoSil, če se ga uporablja za tesnjenje dure mater.
It is not known whether rilpivirine or tenofovir alafenamide are excreted in human milk.
Ni znano, ali se rilpivirin ali alafenamidtenofovirat izločata v materino mleko.
It is not known whether sildenafil enters the breast milk.
Ni znano, ali sildenafil prehaja v materino mleko.
It is not known whether sodium oxybate and/or its metabolites are excreted into breast milk.
Ni znano, ali se natrijev oksibat in/ali njegovi metaboliti izločajo v materino mleko.
It is not known whether sofosbuvir or velpatasvir, the two active substances of Epclusa, pass into human breast milk.
Ni znano, ali sofosbuvir ali velpatasvir, dve zdravilni učinkovini v zdravilu Epclusa, prehajata v materino mleko.
It is not known whether Stivarga alters the ability to drive or use machines.
Ni znano, ali zdravilo Stivarga vpliva na sposobnost vožnje ali upravljanja s stroji.
It is not known whether Targretin has an effect on your ability to drive a car or operate machinery.
Ni znano, ali Targretin vpliva na sposobnost upravljanja vozil in strojev.
It is not known whether tasonermin is excreted in human milk.
Ni znano, ali se tasonermin izloča z materinim mlekom.
It is not known whether technetium Tc 99m tilmanocept is excreted into human milk.
Ni znano, ali se s tehnecijem Tc99m označen tilmanocept izloča v materino mleko.
It is not known whether tenofovir alafenamide is excreted in human milk.
Ni znano, ali se alafenamidtenofovirat izloča v materino mleko.
It is not known whether the active substance in this medicine passes into breast milk.
Ni znano, ali zdravilna učinkovina v tem zdravilu prehaja v materino mleko.
It is not known whether the active substance in Zydelig passes into human milk.
Ni znano, ali se zdravilna učinkovina zdravila Zydelig izloča v materino mleko.
It is not known whether the co-administration of Descovy and xanthine oxidase inhibitors (e.g., febuxostat) would increase systemic exposure to tenofovir.
Ni znano, ali sočasno dajanje zdravila Descovy in zaviralcev ksatin-oksidaze (npr. febuksostata) poveča sistemsko izpostavljenost tenofovirju.
It is not known whether the co-administration of Genvoya and xanthine oxidase inhibitors (e.g., febuxostat) would increase systemic exposure to tenofovir.
Ni znano, ali sočasno dajanje zdravila Genvoya in zaviralcev ksatin-oksidaze (npr. febuksostata) poveča sistemsko izpostavljenost tenofovirju.
It is not known whether the co-administration of tenofovir alafenamide and xanthine oxidase inhibitors (e.g. febuxostat) would increase systemic exposure to tenofovir.
Ni znano, ali sočasno dajanje alafenamidtenofovirata in zaviralcev ksatin-oksidaze (npr. febuksostata) poveča sistemsko izpostavljenost tenofovirju.
It is not known whether the effect will be different in the therapeutic situation (higher lenalidomide doses and concomitant treatment with dexamethasone).
Ni znano, ali bi bil ta učinek v terapevtskih pogojih (večji odmerki lenalidomida in sočasno zdravljenje z deksametazonom) različen.
It is not known whether the ingredients in Celsentri can also pass into your breast milk.
Ni znano, ali sestavine zdravila CELSENTRI lahko prehajajo v materino mleko.
It is not known whether the ingredients in Tecfidera pass into breast milk.
Ni znano, ali sestavine zdravila Tecfidera prehajajo v materino mleko.
It is not known whether the ingredients in Votrient pass into breast-milk.
Ni znano, če se sestavine zdravila Votrient izločajo z materinim mlekom.
It is not known whether the ingredients in Zelboraf pass into human milk.
Ni znano, ali sestavine zdravila Zelboraf prehajajo v materino mleko.
It is not known whether the ingredients of ANORO can pass into breast milk.
Ni znano, ali lahko sestavine zdravila ANORO prehajajo v materino mleko.
It is not known whether the ingredients of Incruse can pass into breast milk.
Ni znano, ali lahko sestavine zdravila Incruse prehajajo v materino mleko.
It is not known whether the ingredients of LAVENTAIR can pass into breast milk.
Ni znano, ali lahko sestavine zdravila LAVENTAIR prehajajo v materino mleko.
It is not known whether the ingredients of Mekinist can pass into breast milk.
Ni znano, ali lahko sestavine zdravila Mekinist prehajajo v materino mleko.
It is not known whether the Janus Associated Kinase (JAK) inhibition by Jakavi reduces the efficacy of the haematopoietic growth factors or whether the haematopoietic growth factors affect the efficacy of Jakavi (see section 4.4).
Ni znano, ali zdravilo Jakavi z zaviranjem Janus kinaz (JAK) zmanjšuje učinkovitost hematopoetskih rastnih dejavnikov oziroma ali hematopoetski rastni dejavniki vplivajo na učinkovitost zdravila Jakavi (glejte poglavje 4.4).
It is not known whether the observed effects would apply to administration of non- adjuvanted seasonal influenza vaccine after a single dose of Pandemrix or when longer dose intervals have elapsed since administration of Pandemrix.
Ni znano, ali bi ta učinek opazili tudi pri uporabi sezonskega cepiva proti gripi brez adjuvansa po enem odmerku cepiva Pandemrix ali če bi od uporabe cepiva Pandemrix minilo več časa.
It is not known whether this active substance is excreted in human milk, however, the enzyme is likely to be digested in the child’s gastrointestinal tract
Ni znano, ali se ta zdravilna učinkovina izloča v materino mleko, vendar se bo encim verjetno presnovil v otrokovih prebavilih.
It is not known whether this medicine can pass into breast milk.
Ni znano, ali lahko sestavine tega zdravila prehajajo v materino mleko.
It is not known whether this medicine is excreted in human milk.
Ni znano, ali se zdravilo pri ljudeh izloča v materinem mleku.
It is not known whether this medicine is excreted in human milk.
Ni znano, ali se zdravilo pri ljudeh izloča v materino mleko.
It is not known whether Thyrogen can affect fertility in humans.
Ni znano, ali lahko zdravilo Thyrogen vpliva na plodnost pri človeku.
It is not known whether TMZ is excreted in human milk; thus, breast-feeding should be discontinued while receiving treatment with TMZ.
Ni znano, ali se TMZ pri ljudeh izloča v materino mleko, zato je treba v obdobju zdravljenja s temozolomidom prekiniti dojenje.
It is not known whether TMZ is excreted in human milk; thus, breast-feeding should be discontinued while receiving treatment with TMZ.
Ni znano, ali se TMZ pri ljudeh izloča v materino mleko, zato je treba v obdobju zdravljenja s TMZ prekiniti dojenje.
It is not known whether treatment with Tecfidera might reduce the effectiveness of some vaccines.
Ni znano, ali lahko zdravljenje z zdravilom Tecfidera zmanjša učinkovitost nekaterih cepiv.
It is not known whether unchanged enoxaparin is excreted in human breast milk.
Ni znano, ali se nespremenjeni enoksaparin izloča v materino mleko.
It is not known whether unchanged enoxaparin sodium is excreted in human milk.
Ni znano, ali se nespremenjeni enoksaparin izloča v materino mleko pri človeku.
It is not known whether vedolizumab is excreted in human milk.
Ni znano, če se vedolizumab izloča v materino mleko.
It is not known whether velaglucerase alfa is excreted in human milk.
Ni znano, ali se velagluceraza alfa izloča v materino mleko.
It is not known whether Vimizim is excreted in human breast milk.
Ni znano, ali se zdravilo Vimizim izloča v materino mleko.
It is not known whether Xigris is excreted in human milk or if there is a potential effect on the breast- fed infant.
Ni znano, ali se zdravilo Xigris izloča v materino mleko in ali obstaja možno tveganje za dojenega otroka.
It is not known whether Xyrem passes into breast milk.
Ni znano, ali zdravilo Xyrem prehaja v materino mleko.
It is not known whether Zinbryta is secreted in human milk.
Ni znano, ali se zdravilo Zinbryta izloča v materino mleko.
It is not necessary to close and shake the bottle before you use the drops for your other eye.
Preden uporabite kapljice na drugem očesu, vam ni treba zapreti in stresati kapalnega vsebnika.
It is not necessary to modify the Rapamune loading dose.
Polnitvenega odmerka ni treba prilagoditi.
It is not possible to determine whether these events were related directly to tadalafil.
Ni možno ugotoviti, ali so ti učinki direktno povezani s tadalafilom.
It is not recommended for patients to apply Panretin gel concurrently with products that contain N,N- diethyl-m-toluamide (DEET ), a common component of insect repellent products.
Bolnikom ne priporočamo uporabe zdravila Panretin gel hkrati z izdelki, ki vsebujejo N,N-dietil-m- toluamid (DEET), kar je običajna sestavina pri sredstvih za zaščito pred insekti (repelenti).
It is not recommended for patients with severely reduced kidney function.
Za bolnike z resnimi težavami z ledvicami zdravilo ni priporočljivo.
It is not recommended if you have severe heart failure.
Uporaba zdravila ni priporočena za bolnike s hudim popuščanjem srca.
It is not recommended that Rapamune be taken with rifampicin, ketoconazole or voriconazole.
Jemanje zdravila Rapamune skupaj z rifampicinom, ketokonazolom ali vorikonazolom ni priporočljivo;
It is not recommended to
Potrebna je previdnost.
It is not recommended to
Priporoča se
It is not recommended to
priporočljiva, saj lahko
It is not recommended to
Sočasna uporaba
It is not recommended to
Sočasna uporaba zdravila
It is not recommended to
Sočasne uporabe
It is not recommended to
Sočasno dajanje zdravila
It is not recommended to
Sočasno uporaba zdravila
It is not recommended to
Uporaba avanafila z zdravilom
It is not recommended to breast-feed your baby while taking Vimpat, as it is not known if Vimpat passes into the breast milk.
Ker ni znano, ali zdravilo Vimpat prehaja v materino mleko, v času jemanja zdravila Vimpat ni priporočljivo dojiti.
It is not recommended to co-
Zato je pri sočasnem dajanju potrebna previdnost.
It is not recommended to co-
Zato sočasna uporaba
It is not recommended to co- administer atazanavir/ritonavir and Viramune (see section 4.4).
Sočasnega dajanja atazanavirja z ritonavirjem in zdravila Viramune ne priporočajo (glejte poglavje 4.4).
It is not recommended to co- administer boceprevir and Nevirapine Teva (see section 4.4).
Sočasno dajanje boceprevirja in zdravila Nevirapin Teva ni priporočeno (glejte poglavje 4.4).
It is not recommended to co- administer efavirenz and Viramune (see section 4.4), because of additive toxicity and no benefit in terms of efficacy over either NNRTI alone (for results of 2NN study, see section 5.1).
Sočasnega dajanja efavirenza in zdravila Viramune ne priporočamo (glejte poglavje 4.4), ker se toksični učinki seštevajo in v primerjavi z dajanjem enega ali drugega NNRTI samega ni dodatne koristi (za rezultate študije 2NN glejte poglavje 5.1).
It is not recommended to co- administer EVOTAZ with simeprevir.
Zdravila EVOTAZ ni priporočljivo uporabljati skupaj s simeprevirjem.
It is not recommended to co- administer fosamprenavir and Viramune if fosamprenavir is not co- administered with ritonavir (see section 4.4).
Če fosamprenavirja ne dajemo hkrati z ritonavirjem, sočasne uporabe fosamprenavirja in zdravila Viramune ne priporočamo (glejte poglavje 4.4).
It is not recommended to co- administer ketoconazole and Nevirapine Teva (see section 4.4).
Sočasno dajanje ketokonazola in zdravila Nevirapin Teva ni priporočeno (glejte poglavje 4.4).
It is not recommended to co- administer ketoconazole and Viramune (see section 4.4).
Sočasnega dajanja ketokonazola in zdravila Viramune ne priporočajo (glejte poglavje 4.4).
It is not recommended to co- administer ketoconazole and Viramune (see section 4.4).
Sočasnega dajanja ketokonazola in zdravilo Viramune ne priporočajo (glejte poglavje 4.4).
It is not recommended to co-administer
Sočasna uporaba darunavirja/ritonavirja in
It is not recommended to co-administer
Sočasna uporaba fosamprenavirja/ritonavirja
It is not recommended to co-administer
Sočasna uporaba lopinavirja/ritonavirja in
It is not recommended to co-administer boosted PREZISTA and boceprevir.
Sočasna uporaba okrepljenega zdravila PREZISTA in boceprevirja ni priporočljiva.
It is not recommended to co-administer boosted PREZISTA and boceprevir.
zdravila PREZISTA in simeprevirja
It is not recommended to co-administer boosted PREZISTA and simeprevir.
primerjavi s skupino, ki je uporabila samo
It is not recommended to co-administer boosted PREZISTA and telaprevir.
Sočasno uporaba okrepljenega zdravila PREZISTA in telaprevirja ni priporočljiva.
It is not recommended to co-administer Eviplera with other NNRTIs.
Sočasna uporaba zdravila Eviplera z drugimi NNRTI-ji se ne priporoča.
It is not recommended to co-administer Kaletra and boceprevir.
Zato sočasna uporaba zdravila
It is not recommended to co-administer Kaletra and simeprevir.
Kaletra in teh glukokortikoidov ni
It is not recommended to co-administer Kaletra and telaprevir.
glukokortikoida (ob tem je treba
It is not recommended to co-administer Kaletra and telaprevir.
Sočasna uporaba zdravila Kaletra s tadalafilom ni priporočljiva.
It is not recommended to co-administer OLYSIO with any HIV PI, with or without ritonavir.
Protiretrovirusna zdravila – zaviralci proteaze (PI)
It is not recommended to co-administer OLYSIO with darunavir/ritonavir.
Sočasna uporaba zdravila OLYSIO z delavirdinom, etravirinom ali nevirapinom ni priporočljiva.
It is not recommended to co-administer OLYSIO with delavirdine, etravirine or nevirapine.
Sočasna uporaba zdravila OLYSIO z efavirenzom ni priporočljiva, saj lahko povzroči izgubo terapevtskega učinka zdravila OLYSIO.
It is not recommended to co-administer OLYSIO with milk thistle.
Sočasna uporaba zdravila OLYSIO s pegastim badljem ni priporočljiva
It is not recommended to co-administer OLYSIO with products containing St John’s wort as co-administration may result in loss of therapeutic effect of OLYSIO.
Sočasna uporaba zdravila OLYSIO s pripravki, ki vsebujejo šentjanževko, ni priporočljiva, saj lahko povzroči izgubo terapevtskega učinka zdravila OLYSIO.
It is not recommended to coadminister efavirenz and Nevirapine Teva (see section 4.4), because of additive toxicity and no benefit in terms of efficacy over either NNRTI alone (for results of 2NN study, see section 5.1).
Sočasno dajanja efavirenza in zdravila Nevirapin Teva ni priporočeno (glejte poglavje 4.4), ker se toksični učinki seštevajo in v primerjavi z dajanjem enega ali drugega NNRTI samega ni dodatne koristi (za rezultate študije 2NN, glejte poglavje 5.1).
It is not recommended to combine INTELENCE with any of the following medicines: tipranavir/ritonavir (anti-HIV medicine)
Odsvetujemo uporabo zdravila INTELENCE skupaj z naslednjimi zdravili: tipranavir/ritonavir (zdravilo proti HIV)
It is not recommended to combine PREZISTA co-administered with
Kombiniranje zdravila PREZISTA z majhnim odmerkom ritonavirja in
It is not recommended to drink alcohol during treatment with Leflunomide Winthrop.
Med zdravljenjem z zdravilom Leflunomid Winthrop ni priporočljivo pitje alkohola.
It is not recommended to drive or operate machines for the first 15 days after Foscan injection, because of the recommended light exposure restrictions
Zaradi priporočenih omejitev izpostavljanja svetlobi prvih 15 dni po injiciranju zdravila Foscan vožnja oziroma upravljanje strojev nista priporočena.
It is not recommended to inject into areas where the skin is tender, bruised, red, or hard.
Ne injicirajte v predele občutljive, poškodovane, pordele ali otrdele kože.
It is not recommended to lower the plasma tyrosine concentration by reduction or discontinuation of nitisinone, since the metabolic defect may result in deterioration of the patient’s clinical condition.
Koncentracije tirozina v plazmi ni priporočljivo zniževati z zmanjšanjem ali prekinitvijo dajanja nitizinona, ker lahko presnovna motnja poslabša bolnikovo klinično stanje.
It is not recommended to take Aloxi in the days following chemotherapy unless you are receiving another chemotherapy cycle.
Zdravila Aloxi ni priporočljivo jemati v dneh, ki sledijo kemoterapiji, razen če prejemate naslednji ciklus kemoterapije.
It is not recommended to take Vimpat if you are pregnant, as the effects of Vimpat on pregnancy and the unborn baby are not known.
V času nosečnosti jemanje zdravila Vimpat ni priporočljivo, ker učinki zdravila Vimpat na nosečnost in nerojenega otroka niso znani.
It is not recommended to use FORCALTONIN in children.
Uporabo FORCALTONINA pri otrocih odsvetujemo.
It is not recommended to use Procox in young puppies of Collie or related breeds since it has not been investigated whether these dogs are more sensitive to treatment with emodepside.
Uporaba zdravila Procox ni priporočena pri pasjih mladičih pasem Collie in njim sorodnih pasmah, saj ni bilo raziskano, ali so ti psi bolj občutljivi na zdravljenje z emodepsidom.
It is not recommended to use REYATAZ with ritonavir for pregnant patients who are receiving both tenofovir and an H2-receptor antagonist.
Uporaba zdravila REYATAZ z ritonavirjem ni priporočljiva pri nosečih bolnicah, ki prejemajo tako tenofovir kot antagonist receptorjev H2.
It is not yet fully established whether immunocompetent individuals who have responded to hepatitis A vaccination will require booster doses as protection in the absence of detectable antibodies may be ensured by immunological memory.
Še vedno ni popolnoma dognano, če imunsko kompetentne osebe, ki so se odzvale na cepljenje s cepivom proti hepatitisu A, potrebujejo poživitveni odmerek, saj kljub temu, da se protiteles ne zazna, zaščito lahko zagotavlja imunološki spomin.
It is not yet fully established whether immunocompetent individuals who have responded to hepatitis A vaccination will require booster doses as protection in the absence of detectable antibodies may be insured by immunological memory.
Še vedno ni popolnoma dognano, če imunsko kompetentne osebe, ki so se odzvale na cepljenje s cepivom proti hepatitisu A, potrebujejo obnovitveni odmerek, saj kljub temu, da se protiteles ne zazna, zaščito lahko zagotavlja imunološki spomin.
It is not yet known how the risk of a blood clot with IOA compares to the risk with a combined hormonal contraceptive that contains levonorgestrel.
Ni še znano, kakšno je tveganje za nastanek krvnega strdka med uporabo zdravila IOA v primerjavi s tveganjem med uporabo kombiniranega hormonskega kontraceptiva, ki vsebuje levonorgestrel.
It is not yet known how the risk of a blood clot with Zoely compares to the risk with a combined hormonal contraceptive that contains levonorgestrel.
Ni še znano, kakšno je tveganje za nastanek krvnega strdka med uporabo zdravila Zoely v primerjavi s tveganjem med uporabo kombiniranega hormonskega kontraceptiva, ki vsebuje levonorgestrel.
It is not yet known how the risk of VTE with CHCs that contain nomegestrol acetate in combination with estradiol compares with the risk with low dose levonorgestrel-containing CHCs.
Ni še znano, kakšno je tveganje za VTE pri CHC, ki vsebujejo nomegestrolacetat v kombinaciji z estradiolom, v primerjavi s tveganjem pri CHC, ki vsebujejo majhen odmerek levonorgestrela.
It is not yet known if this medicine affects fertility in women.
Ni še znano, ali to zdravilo vpliva na plodnost pri ženskah.
It is not yet known, however, whether Praluent will reduce cardiovascular disease, as data on long-term cardiovascular outcomes are still pending.
Vendar pa še ni znano, ali bo zdravilo Praluent zmanjšalo srčno-žilne bolezni, saj se podatki o dolgoročnih srčno-žilnih izidih še pričakujejo.
It is not yet known, however, whether Repatha will reduce cardiovascular disease.
Vendar še ni znano, ali bo zdravilo Repatha zmanjšalo pojav srčno-žilnih bolezni.
It is noted that hypersensitivity is a listed ADR in the timolol Product Information.
Preobčutljivost je navedena kot neželeni učinek v informacijah o zdravilni učinkovini timolol.
It is noted that other Angiotensin Receptor Blockers has thrombocytopenia listed as Adverse Drug Reaction (ADR) in the Product Information, as well as irbesartan in the FDA product information.
Opozoriti velja, da imajo drugi antagonisti receptorjev angiotenzina v informacijah o zdravilu kot neželen učinek navedeno trombocitopenijo; enako velja za irbesartan v informacijah o zdravilu, ki jih je odobrila FDA.
It is of note that 42 (31.6%) patients in the chemotherapy arm subsequently received an anti-PD1 treatment.
Upoštevati je treba, da se je v skupini s kemoterapijo 42 bolnikov (31,6 %) kasneje zdravilo z anti-PD1.